Published in:
Volume 9 / Year 2020 / Issue 3

Quality standards for biopharmaceuticals: the importance of good manufacturing practice

Page: 97-9, 124

Abstract: Regulatory standards for recombinant DNA (rDNA)-derived medicinal products put in place over 40 years ago provided a framework for moving forward with novel biotechnologies and biosimilars leading to their… Read More »

Go Back Print